Page last updated: 2024-10-31

moxisylyte and Vertigo

moxisylyte has been researched along with Vertigo in 1 studies

Moxisylyte: An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)

Vertigo: An illusion of movement, either of the external world revolving around the individual or of the individual revolving in space. Vertigo may be associated with disorders of the inner ear (EAR, INNER); VESTIBULAR NERVE; BRAINSTEM; or CEREBRAL CORTEX. Lesions in the TEMPORAL LOBE and PARIETAL LOBE may be associated with FOCAL SEIZURES that may feature vertigo as an ictal manifestation. (From Adams et al., Principles of Neurology, 6th ed, pp300-1)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Naftalin, L1
Mallett, KJ1

Other Studies

1 other study available for moxisylyte and Vertigo

ArticleYear
Case report of ?hormonal vertigo.
    The Journal of laryngology and otology, 1980, Volume: 94, Issue:3

    Topics: Adult; Endocrine System Diseases; Female; Humans; Menstruation; Moxisylyte; Pregnancy; Pregnancy Com

1980